Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
176.01
+1.55 (0.89%)
Mar 9, 2026, 3:26 PM EDT - Market open
CRL Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 27, 2025 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 25, 2021 | 2020 - 2016 |
| Revenue | 4,015 | 4,050 | 4,129 | 3,976 | 3,540 | Upgrade
|
| Revenue Growth (YoY) | -0.85% | -1.92% | 3.86% | 12.31% | 21.07% | Upgrade
|
| Cost of Revenue | 2,611 | 2,642 | 2,600 | 2,508 | 2,203 | Upgrade
|
| Gross Profit | 1,405 | 1,408 | 1,529 | 1,468 | 1,337 | Upgrade
|
| Selling, General & Admin | 727.81 | 723.62 | 742.85 | 655.58 | 578.23 | Upgrade
|
| Amortization of Goodwill & Intangibles | 179.07 | 138.47 | 137.44 | 146.58 | 124.86 | Upgrade
|
| Operating Expenses | 906.88 | 862.09 | 880.29 | 802.15 | 703.08 | Upgrade
|
| Operating Income | 497.76 | 545.86 | 648.89 | 665.51 | 634.39 | Upgrade
|
| Interest Expense | -107.03 | -126.29 | -136.71 | -59.29 | -73.91 | Upgrade
|
| Interest & Investment Income | 4.94 | 8.58 | 5.2 | 0.78 | 0.65 | Upgrade
|
| Earnings From Equity Investments | -24.91 | -12.91 | 97.83 | -26.78 | -30.42 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | -46.53 | -31.83 | Upgrade
|
| Other Non Operating Income (Expenses) | 3.35 | 2.03 | 1.82 | -18.4 | 7.79 | Upgrade
|
| EBT Excluding Unusual Items | 374.11 | 417.26 | 617.03 | 515.3 | 506.67 | Upgrade
|
| Merger & Restructuring Charges | -101.01 | -108.49 | -34.78 | -15.71 | -45.96 | Upgrade
|
| Impairment of Goodwill | -165 | -215 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 3.38 | -0.66 | -0.96 | 123.41 | 20 | Upgrade
|
| Asset Writedown | -210.97 | - | - | - | - | Upgrade
|
| Pretax Income | -99.5 | 93.11 | 581.28 | 622.99 | 480.71 | Upgrade
|
| Income Tax Expense | 42.66 | 67.82 | 100.91 | 130.38 | 81.87 | Upgrade
|
| Earnings From Continuing Operations | -142.16 | 25.29 | 480.37 | 492.61 | 398.84 | Upgrade
|
| Net Income to Company | -142.16 | 25.29 | 480.37 | 492.61 | 398.84 | Upgrade
|
| Minority Interest in Earnings | -2.18 | -3.09 | -5.75 | -6.38 | -7.86 | Upgrade
|
| Net Income | -144.34 | 22.2 | 474.62 | 486.23 | 390.98 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | 11.91 | - | - | - | Upgrade
|
| Net Income to Common | -144.34 | 10.3 | 474.62 | 486.23 | 390.98 | Upgrade
|
| Net Income Growth | - | -95.32% | -2.39% | 24.36% | 7.32% | Upgrade
|
| Shares Outstanding (Basic) | 50 | 51 | 51 | 51 | 50 | Upgrade
|
| Shares Outstanding (Diluted) | 50 | 52 | 51 | 51 | 51 | Upgrade
|
| Shares Change (YoY) | -4.00% | 0.34% | 0.29% | -0.24% | 1.61% | Upgrade
|
| EPS (Basic) | -2.91 | 0.20 | 9.27 | 9.57 | 7.77 | Upgrade
|
| EPS (Diluted) | -2.91 | 0.20 | 9.22 | 9.48 | 7.60 | Upgrade
|
| EPS Growth | - | -97.83% | -2.74% | 24.74% | 5.56% | Upgrade
|
| Free Cash Flow | 518.49 | 501.61 | 365.37 | 294.91 | 532.03 | Upgrade
|
| Free Cash Flow Per Share | 10.46 | 9.72 | 7.10 | 5.75 | 10.35 | Upgrade
|
| Gross Margin | 34.98% | 34.76% | 37.03% | 36.91% | 37.78% | Upgrade
|
| Operating Margin | 12.40% | 13.48% | 15.71% | 16.74% | 17.92% | Upgrade
|
| Profit Margin | -3.60% | 0.25% | 11.49% | 12.23% | 11.04% | Upgrade
|
| Free Cash Flow Margin | 12.91% | 12.38% | 8.85% | 7.42% | 15.03% | Upgrade
|
| EBITDA | 876.57 | 870.5 | 963.02 | 969.38 | 899.93 | Upgrade
|
| EBITDA Margin | 21.83% | 21.49% | 23.32% | 24.38% | 25.42% | Upgrade
|
| D&A For EBITDA | 378.81 | 324.64 | 314.12 | 303.87 | 265.54 | Upgrade
|
| EBIT | 497.76 | 545.86 | 648.89 | 665.51 | 634.39 | Upgrade
|
| EBIT Margin | 12.40% | 13.48% | 15.71% | 16.74% | 17.92% | Upgrade
|
| Effective Tax Rate | - | 72.84% | 17.36% | 20.93% | 17.03% | Upgrade
|
| Revenue as Reported | 4,015 | 4,050 | 4,129 | 3,976 | 3,540 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.